Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Barratt

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
Pediatric Nephrology (Berlin, Germany)|October 6, 2016
Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohortRosanna Coppo, Danilo Lofaro, Roberta R Camilla, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 2, 2020
Identifying Outcomes Important to Patients with Glomerular Disease and Their CaregiversSimon A Carter, Talia Gutman, Charlotte Logeman, et al.
Pediatric Nephrology (Berlin, Germany)|August 26, 2016
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohortRosanna Coppo, Danilo Lofaro, Roberta R Camilla, et al.
Kidney International|July 3, 2009
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility, Ian S D Roberts, H Terence Cook, et al.
Kidney International Reports|January 22, 2026
A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative WorkshopLouise Oni, Rona Smith, Seza Ozen, et al.
Kidney International|July 3, 2009
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification, Daniel C Cattran, Rosanna Coppo, et al.
Kidney International Reports|January 10, 2022
A Focus Group Study of Self-Management in Patients With Glomerular DiseaseSimon A Carter, Claris Teng, Talia Gutman, et al.
Kidney International|March 5, 2010
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults, Rosanna Coppo, Stéphan Troyanov, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 13, 2018
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) updateRosanna Coppo, Graziella D'Arrigo, Giovanni Tripepi, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
Pediatric Nephrology (Berlin, Germany)|October 6, 2016
Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohortRosanna Coppo, Danilo Lofaro, Roberta R Camilla, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 2, 2020
Identifying Outcomes Important to Patients with Glomerular Disease and Their CaregiversSimon A Carter, Talia Gutman, Charlotte Logeman, et al.
Pediatric Nephrology (Berlin, Germany)|August 26, 2016
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohortRosanna Coppo, Danilo Lofaro, Roberta R Camilla, et al.
Kidney International|July 3, 2009
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility, Ian S D Roberts, H Terence Cook, et al.
Kidney International Reports|January 22, 2026
A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative WorkshopLouise Oni, Rona Smith, Seza Ozen, et al.
Kidney International|July 3, 2009
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification, Daniel C Cattran, Rosanna Coppo, et al.
Kidney International Reports|January 10, 2022
A Focus Group Study of Self-Management in Patients With Glomerular DiseaseSimon A Carter, Claris Teng, Talia Gutman, et al.
Kidney International|March 5, 2010
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults, Rosanna Coppo, Stéphan Troyanov, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 13, 2018
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) updateRosanna Coppo, Graziella D'Arrigo, Giovanni Tripepi, et al.
Pageof 28